Principal investigator, Principal or Chief Investigator
Michael Dobbie
Related Websites
Associated with
Developing a human induced pluripotent stem cell reporter line for heart valve disease modelling
10.82509/WBZA-7B96
Associated with
Development of human GPCR knock-in mice for assessment of therapeutic antibodies
10.82509/SFZJ-8A72
Associated with
Development of iPSC models for ASO screening for TRAPPC4 neurodevelopmental disorder
10.82509/52QH-H634
Associated with
Establishing a targeted treatment strategy using epigenetic reprogramming against adverse EMT-induced tumour plasticity in head and neck (oral) squamous cell carcinoma
10.82509/9603-1820
Associated with
Generation of Oral Carcinoma Patient-Derived Organoids for Personalised Cancer Research
10.82509/MEGH-9025